| Active, not recruiting | 1/2 | 14 | Europe | intra-striatal rAAV5-miHTT, AMT-130 | UniQure Biopharma B.V., uniQure biopharma B.V. | Huntington Disease | 03/29 | 10/29 | | |
NCT06498349: Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl |
|
|
| Recruiting | N/A | 60 | Europe | bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatment, best medical treatment for management of impulse control in Parkinson´s disease, best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group Recommendations | University of Kiel, Insel Gruppe AG, University Hospital Bern, Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC), Philipps University Marburg Medical Center, University Hospital Schleswig-Holstein, Campus Kiel, Czech Technical University in Prague, University of Pennsylvania | Parkinson Disease, Impulse Control Disorders | 07/27 | 07/28 | | |
